AparnaKalyanMD

Oncology • Chicago, IL

Associate Professor of Medicine

Join to view full profile

Dr. Kalyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kalyan's full profile

Already have an account?

Office
645 N Michigan Ave
Ste 1006
Chicago, IL 60611
Phone+1 312-926-2000

Fax+1 312-695-1106

Summary

I am a board certified oncologist specializing in gastrointestinal malignancies.

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 2011 - 2014
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2009 - 2011
The Flinders University of South Australia School of MedicineClass of 2005

Certifications & Licensure

IL State Medical License 2014 - 2026
PA State Medical License 2011 - 2014
OH State Medical License 2009 - 2012

Clinical Trials

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib Start of enrollment: 2019 Feb 08
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer Start of enrollment: 2019 Dec 09
Active, not recruiting
Phase 1
Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors Start of enrollment: 2020 Aug 06
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Canc...
Rachna T Shroff, Gentry King, Sarah Colby, Aaron J Scott, Mitesh J Borad
Journal of Clinical Oncology. 2024-12-13
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer.
Jingquan Jia, Ashley Moyer, Melissa Lowe, Emily Bolch, Jeremy Kortmansky
Journal of Gastrointestinal Cancer. 2024-12-09
Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases.
Andrew C Gordon, Rohan Savoor, Sheetal M Kircher, Aparna Kalyan, Al B Benson 3rd
Journal of Vascular and Interventional Radiology. 2024-11-10

Press Mentions

Mentors and Protégés: Conversations on Career and Craft with Dr. Robert J. Lewandowski, MD, FSIR (2024)November 3rd, 2024

Other Languages

Tamil